MARKET

VOR

VOR

Vor Biopharma Inc.
NASDAQ
8.13
-0.21
-2.46%
Opening 10:17 12/05 EST
OPEN
8.43
PREV CLOSE
8.33
HIGH
8.43
LOW
7.97
VOLUME
35.13K
TURNOVER
--
52 WEEK HIGH
65.80
52 WEEK LOW
2.622
MARKET CAP
178.02M
P/E (TTM)
-0.0210
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VOR last week (1124-1128)?
Weekly Report · 4d ago
Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know
NASDAQ · 11/25 17:00
Vor Biopharma Coverage Assumed by Wedbush at Neutral
Dow Jones · 11/25 14:16
Vor Biopharma Price Target Announced at $9.00/Share by Wedbush
Dow Jones · 11/25 14:16
Wedbush Assumes Vor Biopharma at Neutral, Announces Price Target of $9
Benzinga · 11/25 14:06
Vor Biopharma (VOR) Gets a Hold from Wedbush
TipRanks · 11/25 13:45
Vor Bio assumed with a Neutral at Wedbush
TipRanks · 11/25 13:41
VOR BIOPHARMA INC <VOR.O>: WEDBUSH ASSUMES COVERAGE WITH NEUTRAL RATING; PRICE TARGET $9
Reuters · 11/25 12:28
More
About VOR
Vor Biopharma Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a dual-target fusion protein, through Phase III clinical development and commercialization to address serious autoantibody-driven conditions worldwide. Telitacicept is an investigational recombinant fusion protein designed to treat autoimmune diseases by selectively inhibiting BLyS (BAFF) and APRIL - two cytokines essential to B cell and plasma cell survival. This dual-target mechanism reduces autoreactive B cells and autoantibody production, key drivers of autoimmune pathology. Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase III clinical trial in gMG is underway across the United States, Europe, and South America to support potential approval in the United States and Europe.

Webull offers Vor Biopharma Inc stock information, including NASDAQ: VOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VOR stock methods without spending real money on the virtual paper trading platform.